Duration of treatment of problematic infantile hemangioma with oral propranolol: a single institutional review

Journal Title: IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) - Year 2018, Vol 17, Issue 12

Abstract

Aims: To study the use of propranolol as a single therapy in problematic infantile hemangioma with special reference to the total duration of treatment and its short term outcome(s). Methods: Single institutional retrospective study of patients of problematic infantile hemangioma treated with propranolol between January 2016 to December 2017. Assessment was done by change in colour , redness & size. Accordingly, outcome was graded as excellent, good/partial and no response. Results: 17 girls and 9 boys with problematic infantile hemangioma were initiated treatment with propranolol at the mean age of 7 months(range 2-24 months) for a mean duration of 12 months(range 6-18 months). Head and neck was the most common site(65%). Complete/excellent response was seen in 16 patients(61.6%), good/partial response in 8(30.7%) and no response in 2 patients(7.7%). Rebound was seen in 3 patients(12%). Conclusions: Use of oral propranolol in problematic infantile hemangioma is safe, feasible and effective with very few adverse effects at the recommended dosage of 2-3 mg/kg/day in divided dosage. Treatment should continue till the complete regression of the lesion for at least 12 months substantiated by the fact that all the 3 cases of rebound had received treatment for lesser duration and showed excellent response to longer duration of treatment.

Authors and Affiliations

Sujay Kumar Maitra, Sukanta Kumar Das, Rajarshi Kumar

Keywords

Related Articles

Clinical Profile of ocular Surface Squamous Neoplasia in Southern Odisha

This is an observational study of 31 clinically suspected cases of ocular surface squamous neoplasia (OSSN) at a tertiary care center over a period of two years. The commonest age group involved was above 60 years (58.o6...

Role of Prophylactic Oral Acyclovir in Recurrent Herpes Simplex Eye Disease

Purpose: To study the role of long-term treatment with oral acyclovir to prevent recurrences of ocular HSV disease. Material & methods: A retrospective study was carried out in the Department of Ophthalmology at Governme...

Self Ligating Brackets From Past to Present: An Update

With the consistently advancing orthodontic practices, the idea of self-ligation is promptly acknowledged by clinicians over the globe. Before long, stainless steel and elastomeric ligatures will turn into an obsolete cl...

Maxillary Paramolar: Case Report And Overview

Paramolar is a type of supernumerary teeth that is small and mostly situated buccally or adjacent to maxillary molars. It is a type of developmental disturbance that can occur due to varied etiology. In this case report,...

Dengue Fever: Clinical Spectrum, And Management

Dengue fever a vector borne disease also transmitted via infected blood products and organ donation. Mainly prevalent in Southeast Asia, now has spread to other countries. Worldwide cost of dengue is estimated US 9 billi...

Download PDF file
  • EP ID EP423834
  • DOI 10.9790/0853-1712055859.
  • Views 70
  • Downloads 0

How To Cite

Sujay Kumar Maitra, Sukanta Kumar Das, Rajarshi Kumar (2018). Duration of treatment of problematic infantile hemangioma with oral propranolol: a single institutional review. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), 17(12), 58-59. https://europub.co.uk./articles/-A-423834